| Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches D Tousoulis, N Papageorgiou, E Androulakis, G Siasos, G Latsios, ... Journal of the American College of Cardiology 62 (8), 667-676, 2013 | 328 | 2013 |
| Socioeconomic status and risk factors for cardiovascular disease: impact of dietary mediators T Psaltopoulou, G Hatzis, N Papageorgiou, E Androulakis, A Briasoulis, ... Hellenic journal of cardiology 58 (1), 32-42, 2017 | 261 | 2017 |
| The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure A Briasoulis, E Androulakis, T Christophides, D Tousoulis Heart failure reviews 21, 169-176, 2016 | 201 | 2016 |
| White-coat hypertension and cardiovascular events: a meta-analysis A Briasoulis, E Androulakis, M Palla, N Papageorgiou, D Tousoulis Journal of hypertension 34 (4), 593-599, 2016 | 190 | 2016 |
| Pathophysiology of atherosclerosis: the role of inflammation D Tousoulis, AM Kampoli, N Papageorgiou, E Androulakis, C Antoniades, ... Current pharmaceutical design 17 (37), 4089-4110, 2011 | 174 | 2011 |
| Essential hypertension: is there a role for inflammatory mechanisms? ES Androulakis, D Tousoulis, N Papageorgiou, C Tsioufis, I Kallikazaros, ... Cardiology in review 17 (5), 216-221, 2009 | 130 | 2009 |
| Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes C Bakogiannis, D Tousoulis, E Androulakis, A Briasoulis, N Papageorgiou, ... Current medicinal chemistry 19 (16), 2597-2604, 2012 | 118 | 2012 |
| Fibrinogen and cardiovascular disease: genetics and biomarkers D Tousoulis, N Papageorgiou, E Androulakis, A Briasoulis, C Antoniades, ... Blood reviews 25 (6), 239-245, 2011 | 115 | 2011 |
| Right ventricular dysfunction in critically ill COVID-19 ARDS Int J Cardiol 167 (20), 34166-8, 2020 | 110* | 2020 |
| Inflammatory markers in essential hypertension: potential clinical implications E Stefanadi, D Tousoulis, E S Androulakis, N Papageorgiou, M Charakida, ... Current vascular pharmacology 8 (4), 509-516, 2010 | 91 | 2010 |
| Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches A Briasoulis, D Tousoulis, E S Androulakis, N Papageorgiou, G Latsios, ... Recent Patents on Cardiovascular Drug Discovery (Discontinued) 7 (1), 21-32, 2012 | 83 | 2012 |
| Oxidative stress and early atherosclerosis: novel antioxidant treatment D Tousoulis, T Psaltopoulou, E Androulakis, N Papageorgiou, ... Cardiovascular Drugs and Therapy 29, 75-88, 2015 | 72 | 2015 |
| From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand D Tousoulis, E Androulakis, N Papageorgiou, A Briasoulis, G Siasos, ... Trends in cardiovascular medicine 20 (5), 153-164, 2010 | 71 | 2010 |
| Inflammation in hypertension: current therapeutic approaches E Androulakis, D Tousoulis, N Papageorgiou, G Latsios, G Siasos, ... Current pharmaceutical design 17 (37), 4121-4131, 2011 | 57 | 2011 |
| Assessment of acute coronary syndromes: focus on novel biomarkers D Tousoulis, G Hatzis, N Papageorgiou, E Androulakis, G Bouras, A Giolis, ... Current medicinal chemistry 19 (16), 2572-2587, 2012 | 49 | 2012 |
| Clinical utility of biomarkers in premature atherosclerosis AM Kampoli, D Tousoulis, N Papageorgiou, Z Pallatza, G Vogiatzi, ... Current medicinal chemistry 19 (16), 2521-2533, 2012 | 44 | 2012 |
| Matrix metalloproteinases in acute coronary syndromes: current perspectives AM Kampoli, D Tousoulis, N Papageorgiou, C Antoniades, E Androulakis, ... Current Topics in Medicinal Chemistry 12 (10), 1192-1205, 2012 | 43 | 2012 |
| Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies D Tousoulis, N Papageorgiou, A Briasoulis, E Androulakis, M Charakida, ... Heart failure reviews 17, 65-79, 2012 | 42 | 2012 |
| Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease N Papageorgiou, E Androulakis, S Papaioannou, C Antoniades, ... Amino Acids 47, 1741-1750, 2015 | 40 | 2015 |
| Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease A Briasoulis, D Tousoulis, N Papageorgiou, AM Kampoli, E Androulakis, ... Current topics in medicinal chemistry 12 (10), 1214-1221, 2012 | 39 | 2012 |
Nikolaos PapageorgiouBarts Heart Centre, St. Bartholomew's Hospital在 nhs.net 的电子邮件经过验证
